Sexual Differentiation and Substance Use: A Mini-Review

Area of Science:

• Neuroendocrinology
• Behavioral Neuroscience
• Addiction Research

Background:

• The organizational/activational hypothesis posits distinct roles for gonadal steroids (testosterone, estradiol) during development and adulthood.
• Sex differences in drug addiction are well-documented, with prior research often attributing them to hormonal fluctuations.
• Existing studies highlight estradiol's activational role in female addiction vulnerability, while progesterone may attenuate it.

Purpose of the Study:

• To review the organizational and activational effects of gonadal steroids on behavior, particularly in the context of drug addiction.
• To propose that sex chromosome complement, in addition to hormones, influences sex-specific drug-taking behaviors.
• To advocate for the use of the four core genotype mouse model to disentangle hormonal and chromosomal influences on addiction.

Main Methods:

• Review of existing literature on the organizational/activational hypothesis and sex differences in drug addiction.
• Analysis of studies involving gonadectomized rodents to understand the activational roles of estradiol and progesterone.
• Proposal for utilizing the four core genotype mouse model for future research.

Main Results:

• Gonadal steroids organize neural structures early in life and activate behaviors in adulthood.
• Estradiol facilitates addiction vulnerability in females, while its combination with progesterone attenuates addiction.
• Organizational actions of testosterone, via aromatization to estradiol, impact the neural reward system.

Conclusions:

• Both organizational and activational effects of gonadal steroids contribute to sex differences in drug addiction.
• Sex chromosome complement is a potential, understudied factor in sex-specific drug-taking behaviors.
• The four core genotype mouse model offers a promising approach to differentiate the influences of hormones and sex chromosomes on addiction.